Gemphire Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch GEMP and buy or sell other stocks, options, and ETFs commission-free!About GEMP
Gemphire Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics of dyslipidemia, as well as non-alcoholic fatty liver disease. It offers a small molecule formulated as a tablet product under the Gemcabene brand.
CEOSteve Gullans, PhD
CEOSteve Gullans, PhD
Employees8
Employees8
HeadquartersLivonia, Michigan
HeadquartersLivonia, Michigan
Founded2014
Founded2014
Employees8
Employees8
GEMP Key Statistics
Market cap74.47M
Market cap74.47M
Price-Earnings ratio-1.50
Price-Earnings ratio-1.50
Dividend yield—
Dividend yield—
Average volume28.20K
Average volume28.20K
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$6.75
52 Week high$6.75
52 Week low$2.89
52 Week low$2.89